You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
Merck
McKinsey
AstraZeneca

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CYCLOPENTOLATE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Cyclopentolate Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00348166 Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children? Withdrawn KK Women's and Children's Hospital Phase 1 2005-12-01 The purpose of this study is to find out if undercorrection of myopia slow down the progression of myopia in kindergarten children.
NCT01170130 Lidocaine Usage for Pupil Dilatation (Mydriasis) Completed Carmel Medical Center N/A 2009-12-01 The purpose of this study is to determine if the mydriatic effect of intracameral lidocaine 1% is as effective as topical cyclopentolate 1% and phenylephrine 10% for achieving effective mydriasis during phacoemulsification surgery.
NCT02177539 A New More Efficient Cycloplegia Scheme Unknown status Pontificia Universidad Catolica de Chile Phase 4 2014-05-01 The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme)
NCT02309385 Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis Recruiting National Eye Institute (NEI) Phase 1/Phase 2 2014-10-01 The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis.
NCT02309385 Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis Recruiting Aciont Inc Phase 1/Phase 2 2014-10-01 The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cyclopentolate Hydrochloride

Condition Name

Condition Name for Cyclopentolate Hydrochloride
Intervention Trials
Cataract 3
Myopia 1
Mydriasis 1
Retinopathy of Prematurity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cyclopentolate Hydrochloride
Intervention Trials
Myopia 3
Mydriasis 3
Cataract 3
Refractive Errors 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cyclopentolate Hydrochloride

Trials by Country

Trials by Country for Cyclopentolate Hydrochloride
Location Trials
United States 5
Egypt 1
Chile 1
China 1
Oman 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cyclopentolate Hydrochloride
Location Trials
Utah 1
Texas 1
North Dakota 1
North Carolina 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cyclopentolate Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cyclopentolate Hydrochloride
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 1/Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cyclopentolate Hydrochloride
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cyclopentolate Hydrochloride

Sponsor Name

Sponsor Name for Cyclopentolate Hydrochloride
Sponsor Trials
Carmel Medical Center 1
Sultan Qaboos University 1
KK Women's and Children's Hospital 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cyclopentolate Hydrochloride
Sponsor Trials
Other 11
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
Mallinckrodt
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.